Better Diabetes Control, Quality - Educate to Achieve Compliance.

Completed

• Conditions: Diabetes Type 2

• Registration Number: NCT01728714
• Lead Sponsor: AstraZeneca

Brief Summary

Prospective study to evaluate the impact of an educational programme about diabetes, comparing to normal clinical practice, on treatment compliance and disease control of people with type 2 diabetes followed in the primary care units in Portugal

Detailed Description

Prospective study to evaluate the impact of an educational programme about diabetes focusing on treatment compliance, exercise and nutrition, comparing to normal clinical practice, on treatment compliance and disease control of people with type 2 diabetes followed in the primary care units in Portugal.

Study Timeline

• Study First Submitted: 2012-11-14
• Study First Submitted QC: 2012-11-19
• Study First Posted: 2012-11-20
• Study Start: 2014-05-19
• Primary Completion: 2018-12-05
• Study Completion: 2018-12-05
• Status Verified: 2023-10
• Last Update Submitted: 2023-10-10
• Last Update Posted: 2023-10-12

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 227

Inclusion Criteria

• Individuals with type 2 diabetes
• HbA1c <= 8,5%
• Treated with oral antidiabetics for at least 6 months

Exclusion Criteria

• Treatment with insulin

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Number of people with type 2 diabetes treated with oral antidiabetics assessed as compliant with treatment after 1 year educational programme on diabetes, compared with normal clinical practice.	1 year

Secondary Outcome Measures

Name	Time	Method
Number of people with type 2 diabetes treated with oral antidiabetics assessed as compliant with treatment with oral antidiabetics;after 1 year educational programme on diabetes, compared with normal clinical practice.	1 year
Measure the impact of compliance with treatment on glucose control following 1 year educational programme on diabetes, compared with normal clinical practice.	1 year
Measure level of satisfaction of the patient with treatment and medical care following 1 year educational programme on diabetes, compared with normal clinical practice.	1 year
Number of people with type 2 diabetes treated with oral antidiabetics assessed as compliant with diet and physical exercise after 1 year educational programme on diabetes, compared with normal clinical practice.	1 year
Measure impact on quality of life, perceived by the patient, following 1 year educational programme on diabetes, compared with normal clinical practice.	1 year

Trial Locations

Locations (1)

Research Site; 🇵🇹 Santo Antonio Dos Cavaleiros, Portugal

Research Site

🇵🇹Santo Antonio Dos Cavaleiros, Portugal